Progesterone Receptor Negative Active Not Recruiting Phase 2 Trials for Entinostat (DB11841)

IndicationStatusPhase
DBCOND0038639 (Progesterone Receptor Negative)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01349959Azacitidine and Entinostat in Treating Patients With Advanced Breast CancerTreatment